Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Miller, R."'
Autor:
Mosele MF; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Westphalen CB; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich., Stenzinger A; Institute of Pathology, University Hospital Heidelberg and Center for Personalized Medicine (ZPM), Heidelberg, Germany., Barlesi F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre., Bayle A; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre; Drug Development Department (DITEP), Gustave Roussy, Villejuif; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif., Bièche I; Department of Genetics, Institut Curie, INSERM U1016, Université Paris Cité, Paris, France., Bonastre J; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif., Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid., Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona; University of Vic-Central University of Catalonia, Vic, Spain; Oncoclínicas, São Paulo, Brazil., Krämer A; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany., Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA., Michiels S; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif., Miller R; Department of Medical Oncology, University College London, London; Department of Medical Oncology, St Bartholomew's Hospital, London, UK., Normanno N; Scientific Directorate, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Reis-Filho J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York., Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Robson M; Breast Medicine and Clinical Genetics Services, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Rouleau E; Tumor Genetics Service, Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France., Scarpa A; Section of Pathology, Department of Diagnostics and Public Health, University of Verona-School of Medicine, Verona, Italy., Serrano C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., André F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre. Electronic address: education@esmo.org.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jul; Vol. 35 (7), pp. 588-606. Date of Electronic Publication: 2024 May 27.
Autor:
Martín-Ambrosio Francés M; Animal Health Trust, Newmarket, Suffolk, UK.; Aúna Especialidades Veterinarias, IVC-Evidensia, Paterna, Valencia, Spain., Seth M; Animal Health Trust, Newmarket, Suffolk, UK., Sharman M; Animal Health Trust, Newmarket, Suffolk, UK.; The VetCT Teleconsulting Hospital, Cambridge, UK., Pollard D; The British Horse Society, Kenilworth, Warwickshire, UK., Ortiz AL; School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK., Miller R; Dick White Referrals, Six Mile Bottom, Cambridgeshire, UK.; VetOracle Telemedicine CVS Referrals, Diss, Norfolk, UK., Natsiopoulos T; Dick White Referrals, Six Mile Bottom, Cambridgeshire, UK., Walker D; Anderson Moores Veterinary Specialists, Winchester, Hampshire, UK., Jones B; Anderson Moores Veterinary Specialists, Winchester, Hampshire, UK., Hardwick J; Langford Vets, University of Bristol, Langford, UK.; Cave Veterinary Specialists, West Buckland, Wellington, UK., Glanemann B; Queen Mother Hospital for Animals, The Royal Veterinary College, Hatfield, Hertfordshire, UK., Garcia AS; Pride Veterinary Centre, Derby, UK.; Davies Veterinary Specialists, Higham Gobion, Hitchin, UK., Bacon J; Wear Referrals Veterinary Hospital, Stockton-on-Tees, UK., Selgas AG; Animal Health Trust, Newmarket, Suffolk, UK.; The VetCT Teleconsulting Hospital, Cambridge, UK.
Publikováno v:
Veterinary medicine and science [Vet Med Sci] 2023 Jul; Vol. 9 (4), pp. 1495-1507. Date of Electronic Publication: 2023 May 22.
Autor:
Nelson MH; Aptevo Therapeutics Inc., Seattle, Washington., Fritzell S; Alligator Bioscience AB, Lund, Sweden., Miller R; Aptevo Therapeutics Inc., Seattle, Washington., Werchau D; Alligator Bioscience AB, Lund, Sweden., Van Citters D; Aptevo Therapeutics Inc., Seattle, Washington., Nilsson A; Alligator Bioscience AB, Lund, Sweden., Misher L; Aptevo Therapeutics Inc., Seattle, Washington., Ljung L; Alligator Bioscience AB, Lund, Sweden., Bader R; Aptevo Therapeutics Inc., Seattle, Washington., Deronic A; Alligator Bioscience AB, Lund, Sweden., Chunyk AG; Aptevo Therapeutics Inc., Seattle, Washington., Schultz L; Alligator Bioscience AB, Lund, Sweden., Varas LA; Alligator Bioscience AB, Lund, Sweden., Rose N; Saromics Biostructures AB, Lund, Sweden., Håkansson M; Saromics Biostructures AB, Lund, Sweden., Gross J; Aptevo Therapeutics Inc., Seattle, Washington., Furebring C; Alligator Bioscience AB, Lund, Sweden., Pavlik P; Aptevo Therapeutics Inc., Seattle, Washington., Sundstedt A; Alligator Bioscience AB, Lund, Sweden., Veitonmäki N; Alligator Bioscience AB, Lund, Sweden., Ramos HJ; Aptevo Therapeutics Inc., Seattle, Washington., Säll A; Alligator Bioscience AB, Lund, Sweden., Dahlman A; Alligator Bioscience AB, Lund, Sweden., Bienvenue D; Aptevo Therapeutics Inc., Seattle, Washington., von Schantz L; Alligator Bioscience AB, Lund, Sweden., McMahan CJ; Aptevo Therapeutics Inc., Seattle, Washington., Askmyr M; Alligator Bioscience AB, Lund, Sweden., Hernandez-Hoyos G; Aptevo Therapeutics Inc., Seattle, Washington., Ellmark P; Alligator Bioscience AB, Lund, Sweden.; Department of Immunotechnology, Lund University, Lund, Sweden.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2023 Jan 03; Vol. 22 (1), pp. 89-101.
Autor:
Kronfli D; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland., Savla B; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland., Lievers A; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland., Baker K; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland., Eggleston C; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland., Miller R; Department of Radiation Oncology, UT Medical Center at University of Tennessee, Knoxville, Tennessee., Bentzen SM; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; Department of Epidemiology and Public Health, Biostatistics and Bioinformatics Division, University of Maryland School of Medicine, Baltimore, Maryland., Mohindra P; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland., Vyfhuis MAL; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; Chesapeake Oncology and Hematology Associates, Glen Burnie, Maryland. Electronic address: mvyfhuis@umm.edu.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2022 Oct 01; Vol. 114 (2), pp. 185-194. Date of Electronic Publication: 2022 Apr 29.
Autor:
Griffiths EA; Roswell Park Comprehensive Cancer Center., Roy V; Mayo Clinic Cancer Center., Alwan L; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance., Bachiashvili K; O'Neal Comprehensive Cancer Center at UAB., Baird J; City of Hope National Medical Center., Cool R; The University of Texas MD Anderson Cancer Center., Dinner S; Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Geyer M; Memorial Sloan Kettering Cancer Center., Glaspy J; UCLA Jonsson Comprehensive Cancer Center., Gojo I; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Hicks A; University of Wisconsin Carbone Cancer Center., Kallam A; Fred & Pamela Buffett Cancer Center., Kidwai WZ; Yale Cancer Center/Smilow Cancer Hospital., Kloth DD; Fox Chase Cancer Center., Kraut EH; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Landsburg D; Abramson Cancer Center at the University of Pennsylvania., Lyman GH; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance., Mahajan A; UC Davis Comprehensive Cancer Center., Miller R; Vanderbilt-Ingram Cancer Center., Nachar V; University of Michigan Rogel Cancer Center., Patel S; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Patel S; Huntsman Cancer Institute at the University of Utah., Perez LE; Moffitt Cancer Center., Poust A; University of Colorado Cancer Center., Riaz F; Stanford Cancer Institute., Rosovsky R; Massachusetts General Hospital Cancer Center., Rugo HS; UCSF Helen Diller Family Comprehensive Cancer Center., Simon S; UT Southwestern Simmons Comprehensive Cancer Center., Vasu S; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Wadleigh M; Dana-Farber/Brigham and Women's Cancer Center., Westbrook K; Duke Cancer Institute., Westervelt P; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; and., Berardi RA; National Comprehensive Cancer Network., Pluchino L; National Comprehensive Cancer Network.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2022 May; Vol. 20 (5), pp. 436-442.
Autor:
Jones W; Q2 Solutions - EA Genomics, 5927 S Miami Blvd., Morrisville, NC, 27560, USA. Wendell.Jones@q2labsolutions.com., Gong B; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA., Novoradovskaya N; Agilent Technologies, 11011 N Torrey Pines Rd., La Jolla, CA, 92037, USA., Li D; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA., Kusko R; Immuneering Corporation, One Broadway, 14th Floor, Cambridge, MA, 02142, USA., Richmond TA; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., 4300 Hacienda Dr., Pleasanton, CA, 94588, USA., Johann DJ Jr; Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301 W Markham St., Little Rock, AR, 72205, USA., Bisgin H; Department of Computer Science, Engineering and Physics, University of Michigan-Flint, Flint, MI, 48502, USA., Sahraeian SME; Bioinformatics Research & Early Development, Roche Sequencing Solutions Inc., 1301 Shoreway Rd., Suite 7 #300, Belmont, CA, 94002, USA., Bushel PR; National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC, 27709, USA., Pirooznia M; Bioinformatics and Computational Biology Laboratory, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Wilkins K; Agilent Technologies, 5301 Stevens Creek Blvd., Santa Clara, CA, 95051, USA., Chierici M; Fondazione Bruno Kessler, 38123, Trento, Italy., Bao W; JMP Life Sciences, SAS Institute Inc., Cary, NC, 27519, USA., Basehore LS; Agilent Technologies, 11011 N Torrey Pines Rd., La Jolla, CA, 92037, USA., Lucas AB; Agilent Technologies, 5301 Stevens Creek Blvd., Santa Clara, CA, 95051, USA., Burgess D; (formerly) Research and Development, Roche Sequencing Solutions Inc., 500 South Rosa Rd., Madison, WI, 53719, USA., Butler DJ; Department of Physiology and Biophysics, Weill Cornell Medicine, Cornell University, New York, NY, 10065, USA., Cawley S; (formerly) Clinical Sequencing Division, Thermo Fisher Scientific, 180 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Chang CJ; Stanford Genome Technology Center, Stanford University, Palo Alto, CA, 94304, USA., Chen G; Department of Immunology, Genomics and Microarray Core Facility, University of Texas Southwestern Medical Center, 5323 Harry Hine Blvd., Dallas, TX, 75390, USA., Chen T; University of Texas Southwestern Medical Center, 2330 Inwood Rd., Dallas, TX, 75390, USA., Chen YC; Bioinformatics and Computational Biology Laboratory, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Craig DJ; Department of Medicine, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, 43614, USA., Del Pozo A; Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, CIBERER Instituto de Salud Carlos III, 28046, Madrid, Spain., Foox J; Department of Physiology and Biophysics, Weill Cornell Medicine, Cornell University, New York, NY, 10065, USA., Francescatto M; Fondazione Bruno Kessler, 38123, Trento, Italy., Fu Y; Thermo Fisher Scientific, 110 Miller Ave., Ann Arbor, MI, 48104, USA., Furlanello C; Fondazione Bruno Kessler, 38123, Trento, Italy., Giorda K; Marketing, Integrated DNA Technologies, Inc., 1710 Commercial Park, Coralville, IA, 52241, USA., Grist KP; Q2 Solutions - EA Genomics, 5927 S Miami Blvd., Morrisville, NC, 27560, USA., Guan M; JMP Life Sciences, SAS Institute Inc., Cary, NC, 27519, USA., Hao Y; College of Chemistry, Sichuan University, Chengdu, 610064, Sichuan, China., Happe S; Agilent Technologies, 1834 State Hwy 71 West, Cedar Creek, TX, 78612, USA., Hariani G; Q2 Solutions - EA Genomics, 5927 S Miami Blvd., Morrisville, NC, 27560, USA., Haseley N; Illumina Inc., 5200 Illumina Way, San Diego, CA, 92122, USA., Jasper J; Q2 Solutions - EA Genomics, 5927 S Miami Blvd., Morrisville, NC, 27560, USA., Jurman G; Fondazione Bruno Kessler, 38123, Trento, Italy., Kreil DP; Bioinformatics Research, Institute of Molecular Biotechnology, Boku University Vienna, Vienna, Austria., Łabaj P; Małopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.; Department of Biotechnology, Boku University, Vienna, Austria., Lai K; Bioinformatics, Integrated DNA Technologies, Inc., 1710 Commercial Park, Coralville, IA, 52241, USA., Li J; Kelly Government Solutions, Inc., Research Triangle Park, NC, 27709, USA., Li QZ; Department of Immunology, Genomics and Microarray Core Facility, University of Texas Southwestern Medical Center, 5323 Harry Hine Blvd., Dallas, TX, 75390, USA., Li Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China., Li Z; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China., Liu Z; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA., López MS; Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, CIBERER Instituto de Salud Carlos III, 28046, Madrid, Spain.; EATRIS ERIC- European Infrastructure for Translational Medicine, De Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands., Miclaus K; JMP Life Sciences, SAS Institute Inc., Cary, NC, 27519, USA., Miller R; Agilent Technologies, 5301 Stevens Creek Blvd., Santa Clara, CA, 95051, USA., Mittal VK; Thermo Fisher Scientific, 110 Miller Ave., Ann Arbor, MI, 48104, USA., Mohiyuddin M; Bioinformatics Research & Early Development, Roche Sequencing Solutions Inc., 1301 Shoreway Rd., Suite 7 #300, Belmont, CA, 94002, USA., Pabón-Peña C; Agilent Technologies, 5301 Stevens Creek Blvd., Santa Clara, CA, 95051, USA., Parsons BL; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA., Qiu F; Research and Development, Burning Rock Biotech, Shanghai, 201114, China., Scherer A; EATRIS ERIC- European Infrastructure for Translational Medicine, De Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.; Institute for Molecular Medicine Finland (FIMM), Nordic EMBL Partnership for Molecular Medicine, HiLIFE Unit, Biomedicum Helsinki 2U (D302b), FI-00014 University of Helsinki, P.O. Box 20 (Tukholmankatu 8), Helsinki, Finland., Shi T; Center for Bioinformatics and Computational Biology, and the Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, 500 Dongchuan Rd, Shanghai, 200241, China., Stiegelmeyer S; University of North Carolina Health, 101 Manning Drive, Chapel Hill, NC, 27514, USA., Suo C; Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China., Tom N; EATRIS ERIC- European Infrastructure for Translational Medicine, De Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic., Wang D; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA., Wen Z; College of Chemistry, Sichuan University, Chengdu, 610064, Sichuan, China., Wu L; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA., Xiao W; Stanford Genome Technology Center, Stanford University, Palo Alto, CA, 94304, USA.; Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., Xu C; Research and Development, QIAGEN Sciences Inc., Frederick, MD, 21703, USA., Yu Y; State Key Laboratory of Genetic Engineering, School of Life Sciences and Shanghai Cancer Hospital/Cancer Institute, Fudan University, Shanghai, 200438, China., Zhang J; State Key Laboratory of Genetic Engineering, School of Life Sciences and Shanghai Cancer Hospital/Cancer Institute, Fudan University, Shanghai, 200438, China., Zhang Y; University of Arkansas at Little Rock, Little Rock, AR, 72204, USA., Zhang Z; Research and Development, Burning Rock Biotech, Shanghai, 201114, China., Zheng Y; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA.; State Key Laboratory of Genetic Engineering, School of Life Sciences and Shanghai Cancer Hospital/Cancer Institute, Fudan University, Shanghai, 200438, China., Mason CE; Department of Physiology and Biophysics, Weill Cornell Medicine, Cornell University, New York, NY, 10065, USA., Willey JC; Departments of Medicine, Pathology, and Cancer Biology, College of Medicine and Life Sciences, University of Toledo Health Sciences Campus, 3000 Arlington Ave, Toledo, OH, 43614, USA., Tong W; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA., Shi L; State Key Laboratory of Genetic Engineering, School of Life Sciences and Shanghai Cancer Hospital/Cancer Institute, Fudan University, Shanghai, 200438, China.; Human Phenome Institute, Fudan University, Shanghai, 201203, China.; Fudan-Gospel Joint Research Center for Precision Medicine, Fudan University, Shanghai, 200438, China., Xu J; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA. Joshua.xu@fda.hhs.gov.
Publikováno v:
Genome biology [Genome Biol] 2021 Apr 16; Vol. 22 (1), pp. 111. Date of Electronic Publication: 2021 Apr 16.
Autor:
Miller R; Discipline of Sport and Exercise Science, Faculty of Health, University of Canberra, ACT 2617, Australia. Electronic address: u3160329@uni.canberra.edu.au., Northey J; Discipline of Sport and Exercise Science, Faculty of Health, University of Canberra, ACT 2617, Australia; UC Research Institute for Sport and Exercise, University of Canberra, ACT 2617, Australia., Toohey K; Discipline of Sport and Exercise Science, Faculty of Health, University of Canberra, ACT 2617, Australia; Prehabilitation, Activity, Cancer, Exercise, Survivorship (PACES) Research Group, University of Canberra, Canberra, Australia.
Publikováno v:
Seminars in oncology nursing [Semin Oncol Nurs] 2020 Oct; Vol. 36 (5), pp. 151068. Date of Electronic Publication: 2020 Sep 29.
Autor:
Lee LYW; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, UK. Electronic address: l.lee.2@bham.ac.uk., Hill T; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Topping O; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Tilby M; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Baker M; University of Birmingham Medical School, University of Birmingham, UK., Greig J; University of Birmingham Medical School, University of Birmingham, UK., Isherwood L; University of Birmingham Medical School, University of Birmingham, UK., Miller R; University of Birmingham Medical School, University of Birmingham, UK., Petrenko Y; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Desai R; University of Birmingham Medical School, University of Birmingham, UK., Field A; University of Birmingham Medical School, University of Birmingham, UK., Kennedy B; University of Birmingham Medical School, University of Birmingham, UK., Khan S; University of Birmingham Medical School, University of Birmingham, UK., Kountourou A; University of Birmingham Medical School, University of Birmingham, UK., Ndlovu S; University of Birmingham Medical School, University of Birmingham, UK., Starkey T; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, UK., Storey F; University of Birmingham Medical School, University of Birmingham, UK., Turner L; University of Birmingham Medical School, University of Birmingham, UK., Vaughan-Williams W; University of Birmingham Medical School, University of Birmingham, UK., Moyler S; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Preston H; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Latty B; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Walker S; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Henderson DR; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Thompson J; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Jones N; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Ghafoor Q; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Pascoe J; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Williams S; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Middleton G; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Immunology and Immunotherapy, University of Birmingham, UK. Electronic address: g.middleton@bham.ac.uk.
Publikováno v:
Cancer cell [Cancer Cell] 2020 Sep 14; Vol. 38 (3), pp. 306-307. Date of Electronic Publication: 2020 Jul 24.
Autor:
Stover AM; Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Urick BY; Department of Pharmacy, Center for Medication Optimization in the Division of Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill, Chapel Hill, NC., Deal AM; Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Teal R; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Connected Health Applications and Interventions (CHAI-Core), University of North Carolina at Chapel Hill, Chapel Hill, NC., Vu MB; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Connected Health Applications and Interventions (CHAI-Core), University of North Carolina at Chapel Hill, Chapel Hill, NC.; Center for Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill, Chapel Hill, NC., Carda-Auten J; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Connected Health Applications and Interventions (CHAI-Core), University of North Carolina at Chapel Hill, Chapel Hill, NC., Jansen J; Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Chung AE; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Departments of Medicine and Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC., Bennett AV; Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Chiang A; Yale University and Smilow Cancer Center, Hartford, CT., Cleeland C; University of Texas MD Anderson Cancer Center, Houston, TX., Deutsch Y; Memorial Cancer Center, Hollywood, FL., Tai E; Palo Alto Medical Foundation, Palo Alto, CA., Zylla D; Park Nicollet Oncology Research, Frauenshuh Cancer Center, HealthPartners Institute, Minneapolis, MN., Williams LA; University of Texas MD Anderson Cancer Center, Houston, TX., Pitzen C; MN Community Measurement, Minneapolis, MN., Snyder C; Johns Hopkins University, Baltimore, MD., Reeve B; Duke University, Durham, NC., Smith T; American Cancer Society, Atlanta, GA., McNiff K; KM Healthcare Consulting, Atlanta, GA., Cella D; Northwestern University, Evanston, IL., Neuss MN; Vanderbilt University, Nashville, TN., Miller R; American Society of Clinical Oncology, Alexandria, VA., Atkinson TM; Memorial Sloan Kettering Cancer Center, New York, NY., Spears PA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Patient Advocate., Smith ML; Patient Advocate.; Research Advocacy Network, Naperville, IL., Geoghegan C; Patient Advocate.; Patients & Partners, LLC, Danbury, CT., Basch EM; Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2020 Mar; Vol. 16 (3), pp. e234-e250. Date of Electronic Publication: 2020 Feb 19.
Autor:
Becker PS; University of Washington/Seattle Cancer Care Alliance., Griffiths EA; Roswell Park Comprehensive Cancer Center., Alwan LM; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance., Bachiashvili K; O'Neal Comprehensive Cancer Center at UAB., Brown A; University of Michigan Rogel Cancer Center., Cool R; The University of Texas MD Anderson Cancer Center., Curtin P; UC San Diego Moores Cancer Center., Dinner S; Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Gojo I; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Hicks A; University of Wisconsin Carbone Cancer Center., Kallam A; Fred & Pamela Buffett Cancer Center., Kidwai WZ; Yale Cancer Center/Smilow Cancer Hospital., Kloth DD; Fox Chase Cancer Center., Kraut EH; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Landsburg D; Abramson Cancer Center at the University of Pennsylvania., Lyman GH; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance., Miller R; Vanderbilt-Ingram Cancer Center., Mukherjee S; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Patel S; Huntsman Cancer Institute at the University of Utah., Perez LE; Moffitt Cancer Center., Poust A; University of Colorado Cancer Center., Rampal R; Memorial Sloan Kettering Cancer Center., Rosovsky R; Massachusetts General Hospital Cancer Center., Roy V; Mayo Clinic Cancer Center., Rugo HS; UCSF Helen Diller Family Comprehensive Cancer Center., Shayani S; City of Hope National Medical Center., Vasu S; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Wadleigh M; Dana-Farber Cancer Institute., Westbrook K; Duke Cancer Center., Westervelt P; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; and., Burns J; National Comprehensive Cancer Network., Keller J; National Comprehensive Cancer Network., Pluchino LA; National Comprehensive Cancer Network.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2020 Jan; Vol. 18 (1), pp. 12-22.